RNA sequencing (RNA-Seq) technology enables rapid profiling and deep investigation of the transcriptome, for any species. This approach offers a number of advantages compared to microarray analysis, a legacy technology often used in gene expression studies.
Ability to detect novel transcripts: Unlike arrays, RNA-Seq technology does not require species- or transcript-specific probes. It can detect novel transcripts, gene fusions, single nucleotide variants, indels (small insertions and deletions), and other previously unknown changes that arrays cannot detect.1,2
Wider dynamic range: With array hybridization technology, gene expression measurement is limited by background at the low end and signal saturation at the high end. RNA-Seq technology produces discrete, digital sequencing read counts, and can quantify expression across a larger dynamic range (>105 for RNA-Seq vs. 103 for arrays).1,2,3
Higher specificity and sensitivity: Compared to microarrays, RNA-Seq technology can detect a higher percentage of differentially expressed genes, especially genes with low expression.4-6
Simple detection of rare and low-abundance transcripts: Sequencing coverage depth can easily be increased to detect rare transcripts, single transcripts per cell, or weakly expressed genes.
Access a detailed comparison of microarray and RNA-Seq technologies, from the perspective of a sequencing service provider.
“mRNA-Seq offers improved specificity, so it’s better at detecting transcripts, and specifically isoforms, than microarrays. It’s also more sensitive in detecting differential expression and offers increased dynamic range.”
In the past, next-generation sequencing (NGS) data analysis required extensive bioinformatics expertise, presenting a major hurdle to adoption of RNA sequencing technology by biologists. The latest user-friendly tools vastly simplify the analysis process, providing accessible solutions for researchers without a bioinformatics background.
The NextSeq 2000 System supports a broad range of conventional and emerging applications, from transcriptome sequencing to exome sequencing, single-cell profiling, and more.
The portion of NIH grant funding allocated to new RNA sequencing vs. gene expression microarray-inclusive grants has been trending towards RNA-Seq technology for the last several years, and now constitutes the majority. Download our transcriptomics eBook to see the evidence.
This eBook discusses how NGS is advancing gene expression research, and includes a section on the advantages of RNA-Seq over arrays.
Each RNA sequencing experiment type—whether it’s gene expression profiling, targeted RNA expression, or small RNA analysis—has unique requirements for read length and depth. This bulletin reviews experimental considerations and offers resources to help with study design.
Annika Sonntag, PhD and her team originally used microarrays to measure RNA expression, but needed to see exon-specific RNA expression as well. After comparing many technologies, they chose Illumina NGS for their gene expression studies.
Explore a wide variety of RNA-Seq methods, from mRNA-Seq to specialized methods for analyzing RNA from cancer samples and more.
Our enhanced RNA-Seq library prep portfolio offers rapid turnaround time, broad study flexibility, and sequencing scalability.